Decision Support Tool: Features to Consider in Determining if a Clinical Trial is Phase II or Phase III


A working group led by OBSSR, with participants from other NIH Institutes, Centers, and Offices, releases the Decision Support Tool: Features to Consider in Determining if a Clinical Trial is Phase II or Phase III. It is designed to be a resource to help investigators, program officers, and reviewers determine whether a behavioral or social sciences study is better characterized as a Phase II or a Phase III clinical trial.

Committee to Co-Chair NIH Efforts on Social Determinants of Health


NIH creates an Executive Committee (EC) and Research Coordinating Center (RCC) to coordinate NIH efforts on social determinants of health (SdoH). The co-chairs are the Directors of the National Institute of Nursing Research, the National Institute on Minority Health and Health Disparities, and OBSSR. The overall goal of the NIH SdoH RCC is to accelerate NIH-wide SdoH research across diseases and conditions, populations, stages of the life course, and SdoH domains, domestically and globally.

Special Issue in AJPH related to the Opioid and Pain Crisis


In February 2022, on behalf of the Contributions of Social and Behavioral Research in Addressing the Opioid Crisis committee, OBSSR commissions a special issue in AJPH that provides opportunities for integrating varied expertise and perspectives from a wide range of communities into NIH behavioral and social sciences research efforts related to the opioid and pain crises in the United States.